1-chloro-1-deoxy-scyllo-inositol | 19647-38-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-chloro-1-deoxy-scyllo-inositol
• 英文别名: all-trans-1,2,3,4,5-Pentahydroxy-6-chlorcyclohexan; meso(1,3,5/2,4,6)-6-Chlor-1,2,3,4,5-pentahydroxycyclohexan
• CAS: 19647-38-2
• 化学式: C₆H₁₁ClO₅
• 分子量: 198.603
• InChiKey: BSMLUJHFZGTHOG-CDRYSYESSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.59
• 重原子数：
  12.0
• 可旋转键数：
  0.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  101.15
• 氢给体数：
  5.0
• 氢受体数：
  5.0

反应信息

• 作为产物：
  描述：

  1-O-Benzoyl-2.3.4.5.6-penta-O-methyl-(-)-inosit 在 sodium hydroxide 、 五氯化磷 、 氢溴酸 、 溶剂黄146 作用下， 生成 1-chloro-1-deoxy-scyllo-inositol
  参考文献：
  名称：

  Alicyclic carbohydrates. XXXVI. Participation by neighboring methoxyl in a displacement of hydroxyl by halogen. Conversion of (-)-inositol into meso (1,3,5/2,4)-cycloxhexanepentol

  摘要：

  DOI：

  10.1021/jo01257a041

文献信息

• Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation
  作者：Yedi Sun、Guohua Zhang、Cheryl A. Hawkes、James E. Shaw、JoAnne McLaurin、Mark Nitz

  DOI：10.1016/j.bmc.2008.06.045

  日期：2008.8

  scyllo-inositol derivatives have been synthesized which contain deoxy, fluoro, chloro, and methoxy substitutions. The effects of these compounds on the aggregation cascade of Abeta42 have been investigated using electron microscopy (EM). EM analyses revealed that the 1-deoxy-1-fluoro- and 1,4-dimethyl-scyllo-inositols significantly inhibit the formation of Abeta42 fibers. The other derivatives showed some alterations

  scyllo-肌醇通过与淀粉样蛋白β（Abeta）肽直接相互作用抑制Abeta42纤维形成，已显示出有望作为阿尔茨海默氏病的潜在治疗剂。为了探索肌醇-Abeta42相互作用的分子细节，已合成了一系列含有脱氧，氟，氯和甲氧基取代的鞘氨醇衍生物。这些化合物对Abeta42的聚集级联反应的影响已使用电子显微镜（EM）进行了研究。EM分析表明，1-脱氧-1-氟-和1,4-二甲基-scyllo-肌醇显着抑制Abeta42纤维的形成。其他衍生物在生产的Abeta42纤维的形态上显示出一些变化。
• 1-FLUORO-1-DEOXY-SCYLLO-INOSITOL FOR THE TREATMENT OF ALZHEIMER'S DISEASE
  申请人：Waratah Pharmaceuticals, Inc.

  公开号：EP1940373B1

  公开（公告）日：2015-05-06
• Inositol compounds and uses of same in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence
  申请人：Cruz Antonio

  公开号：US20070111970A1

  公开（公告）日：2007-05-17

  Inositol derivatives are described that are represented by the structural formula I wherein X is a radical of scyllo-inositol wherein one or more of R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are independently alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, sulfoxide, sulfate, sulfonyl, sulfenyl, sulfonate, sulfinyl, amino, imino, azido, thiol, thioalkyl, thioalkoxy, thioaryl, nitro, cyano, halo, seleno, silyl, silyloxy, silylthio, carboxyl, carbonyl, carbamoyl, or carboxamide and the other of R 1 , R 2 , R 3 , R 4 , R 5 , or R 6 are hydroxyl, or pharmaceutically acceptable salts thereof. The compounds, compositions comprising same and methods using same are described for use in the prevention and/or treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence.
• SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCE
  申请人：Cruz Antonio

  公开号：US20090170957A1

  公开（公告）日：2009-07-02

  Scyllo-Inositol derivatives represented by structural formula II are described, wherein at least one and not more than five of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is hydroxyl and the other of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are independently alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, sulfoxide, sulfate, sulfonyl, sulfenyl, sulfonate, sulfinyl, ammo, lmmo, azido, thiol, thioalkyl, thioaryl, mtro, cyano, halo, seleno, silyl, silyloxy, silylthio, carboxyl, carbonyl, carbamoyl or carbamide, or pharmaceutically acceptable salts thereof. Said derivatives and compositions comprising the same are useful in the prevention and/or treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence.
• Inositol Compounds and Uses of Same in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation or Amyloid Formation, Desposition, Accumulation or Persistence
  申请人：Curz Antonio

  公开号：US20100105631A1

  公开（公告）日：2010-04-29

  Inositol derivatives are described that are represented by the structural formula I wherein X is a radical of scyllo-inositol wherein one or more of R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are independently alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, sulfoxide, sulfate, sulfonyl, sulfenyl, sulfonate, sulfinyl, amino, imino, azido, thiol, thioalkyl, thioalkoxy, thioaryl, nitro, cyano, halo, seleno, silyl, silyloxy, silylthio, carboxyl, carbonyl, carbamoyl, or carboxamide and the other of R 1 , R 2 , R 3 , R 4 , R 5 , or R 6 are hydroxyl, or pharmaceutically acceptable salts thereof. The compounds, compositions comprising same and methods using same are described for use in the prevention and/or treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence.